WFDC8

Model summary

A secreted, disulfide-rich extracellular inhibitor that uses a WAP module followed by a Kunitz core and additional WAP repeats to bind and neutralize serine proteases at the cell surface and within matrix-rich niches. By assembling stable inhibitory complexes with pericellular scaffolds, it dampens protease activity and tunes extracellular proteolysis during tissue and host–environment interactions, accumulating in the extracellular space and associating with collagen-rich matrices and transient multiprotein assemblies.

Predicted Gene Ontology terms

1. 01

   I begin by dissecting the InterPro architecture and its order along the sequence.

   The N-terminal third carries IPR036645 (Elafin-like superfamily, residues 38–90) that overlaps with IPR008197 (WAP-type ‘four-disulfide core’ domain, residues 44–91). Immediately downstream sits a canonical serine-protease inhibitor module: IPR036880 (Pancreatic trypsin inhibitor Kunitz domain superfamily, residues 83–149) encompassing IPR002223 (Pancreatic trypsin inhibitor Kunitz domain, residues 92–146) and its catalytic-contacting signature IPR020901 (Proteinase inhibitor I2, Kunitz, conserved site, residues 123–141). The C-terminal half is dominated by WAP/elafin-like repeats: IPR036645 (Elafin-like superfamily, residues 149–194) and IPR036645 (Elafin-like superfamily, residues 194–239) coincide with three WAP-type signatures—IPR008197 (WAP-type ‘four-disulfide core’ domain, residues 147–194), IPR008197 (residues 195–240)—that together form a tandem WAP arrangement. This linear arrangement—an N-terminal WAP module followed by a Kunitz inhibitor core and then tandem WAP repeats—is a hallmark of secreted, disulfide-rich inhibitors that target extracellular serine proteases.

2. 02

   This domain architecture dictates molecular function.

   The Kunitz module (IPR002223 with IPR020901) provides a high-affinity, reversible inhibitory surface that sterically occludes the active site of trypsin-like serine endopeptidases. The flanking WAP domains (IPR008197) and the broader elafin-like superfamily scaffolds (IPR036645) stabilize the inhibitory fold, enhance extracellular resilience via multiple disulfide bonds, and frequently broaden target specificity or localization to pericellular matrices. Together, these modules cause tight, multivalent protein binding to proteases and other extracellular partners, aligning with GO:0005515 protein binding as the operative molecular function label.

3. 03

   From function to process, inhibition of serine endopeptidases directly enacts negative regulation of peptidase activity (GO:0010466).

   By damping pericellular proteolysis, the protein modulates extracellular signaling and matrix turnover. The WAP/Kunitz tandem is classically deployed in host defense and tissue homeostasis; its extracellular stability and matrix affinity position it to curb protease cascades triggered during tissue injury and pathogen exposure, consistent with participation in response to other organism (GO:0051707).

4. 04

   Cellular location follows causally from the signal that this is a secreted, disulfide-rich inhibitor: it operates outside the cell where protease targets reside.

   The presence of WAP and Kunitz modules, together with the absence of transmembrane cores, supports secretion into the extracellular space (GO:0005615). The strong matrix-binding propensity of WAP/elafin-like repeats and their frequent deposition onto fibrillar scaffolds rationalize association with the collagen-containing extracellular matrix (GO:0062023). Many such inhibitors transiently assemble into higher-order inhibitory assemblies and carrier complexes, which situates the protein within protein-containing complexes (GO:0032991). Its pericellular accumulation at the cell boundary—mediated by matrix and protease binding—accounts for cell-surface association (GO:0009986).

5. 05

   Mechanistically, I propose a two-site inhibitory mechanism.

   The Kunitz core forms the principal inhibitory interface that arrests catalysis, while the WAP modules and elafin-like scaffolds create avidity for extracellular matrices and cell surfaces, concentrating the inhibitor where protease flux is highest. This architecture favors transient, high-affinity complexes with trypsin-like proteases and pericellular scaffolds, thereby throttling protease activity and tuning extracellular proteolysis.

6. 06

   From this model, likely interaction partners include extracellular serine proteases (e.g., trypsin-like endopeptidases), pericellular matrix components such as collagens and fibronectin, and cell-surface protease systems (e.g., membrane-anchored proteases and their soluble counterparts).

   These assemblies would allow the protein to patrol and dampen protease cascades at the extracellular interface.